PlexusDx patients receive personalized medication profiles through the Precision Peptide Genetic Test, which identifies individual metabolic responses and can inform safe activity recommendations alongside medical supervision
Zheng T, Yang L, Liu Y, Liu H, Yu J, Zhang X, et al
The dual GIP/GLP-1 receptor agonist tirzepatide represents a novel therapeutic approach, simultaneously activating both incretin pathways
GET ACCESS TO OBESITY CARE AND MEDS AND SUPPORT OTP: USE CODE: OTP25 VISIT ALL OUR LINKS: Visit Our Sponsors
A novel tensor component analysis method (TCAM) 35 , allowing to longitudinally represent the 3-week study as a single compressed dot per animal, revealed that targeting CD38 improved both physical and metabolic features in 5xFAD mice (Fig
Radiotracer imaging studies in patients with AUD (Volkow et al., 1996), cocaine users (Volkow et al., 1993) and methamphetamine users (Volkow et al., 2001) have reported of decreased postsynaptic dopamine receptor availability, which is suggested as one of the explanations for lower dopamine function in this group of patients (Nutt et al., 2015)